Related Experiment Video
Updated: Jul 14, 2026

A High-throughput Method for Measurement of Glomerular Filtration Rate in Conscious Mice
Published on: May 10, 2013
Diabetes-induced hyperfiltration in adenosine A(1)-receptor deficient mice lacking the tubuloglomerular feedback
J Sällström1, P-O Carlsson, B B Fredholm
1Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
Aims:
Glomerular hyperfiltration is commonly found in diabetic patients early after the onset of disease. This is one of the first indications of the development of progressive diabetic nephropathy. It has been proposed that glomerular hyperfiltration is caused by decreased delivery of electrolytes to the macula densa due to the increased sodium and glucose reabsorption in the proximal tubule, which would increase the glomerular filtration rate (GFR) via the tubuloglomerular feedback (TGF) mechanism. In this study, we investigated the role of TGF in diabetes-induced glomerular hyperfiltration by inducing diabetes in adenosine A(1)-receptor knockout (A1AR(-/-)) mice known to lack a functional TGF mechanism.
Methods:
Diabetes was induced by alloxan (75 mg kg(-1) bw) injected into the tail vein. The 24-hour urinary electrolyte excretion was measured in metabolic cages, the GFR determined by inulin clearance under isoflurane-anaesthesia, and histological changes evaluated.
Results:
All alloxan-treated animals developed hyperglycaemia (> or =20 mm). Normoglycaemic animals had a similar GFR independent of genotype (A1AR(+/+) 9.3 +/- 0.5 vs. A1AR(-/-) 10.1 +/- 0.8 microL min(-1)g(-1) bw) and diabetes resulted in similar glomerular hyperfiltration in both groups (A1AR(+/+) 14.0 +/- 1.7, n = 9 vs. A1AR(-/-) 15.3 +/- 1.9 microL min(-1)g(-1) bw). Diabetic animals had a similar tendency to develop interstitial fibrosis, whereas the glomerular volume was similar in both genotypes, and unaltered by diabetes.
Conclusions:
This study shows that the A1AR(-/-) mice develop diabetes-induced glomerular hyperfiltration, demonstrating that the TGF mechanism is not the major cause of the development of hyperfiltration. Furthermore, the hyperfiltration in the present study was not related to alterations in the glomerular filtration area.
Insights
Diabetic kidney disease involves glomerular hyperfiltration, potentially linked to tubuloglomerular feedback (TGF). This study in adenosine A(1)-receptor knockout mice shows TGF is not the primary driver of this early diabetic nephropathy complication.
Area of Science:
- Nephrology
- Endocrinology
- Physiology
Background:
- Glomerular hyperfiltration is an early indicator of diabetic nephropathy.
- The tubuloglomerular feedback (TGF) mechanism is hypothesized to cause hyperfiltration via altered macula densa signaling.
Purpose of the Study:
- To investigate the role of the TGF mechanism in diabetes-induced glomerular hyperfiltration.
- To assess if blocking TGF by deleting the adenosine A(1)-receptor (A1AR) affects hyperfiltration in diabetic mice.
Main Methods:
- Diabetes was induced using alloxan in wild-type and A1AR knockout mice.
- Glomerular filtration rate (GFR) was measured by inulin clearance.
- Urinary electrolytes and histological changes were evaluated.
Main Results:
- Diabetic A1AR knockout mice exhibited similar glomerular hyperfiltration as diabetic wild-type mice.
- Hyperglycemia was confirmed in alloxan-treated animals.
- No significant differences in glomerular volume or interstitial fibrosis were observed between genotypes.
Conclusions:
- The TGF mechanism, mediated by A1AR, is not the primary cause of diabetes-induced glomerular hyperfiltration.
- Glomerular hyperfiltration in this model is independent of the TGF pathway and not related to changes in glomerular filtration area.
Related Concept Videos
Diabetic Nephropathy
Diabetes Insipidus II: Pathophysiology
Diabetes Insipidus I: Introduction
Glomerular Filtration Rate and its Regulation
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
Antihypertensive Drugs: Action of Diuretics
Heart Failure Drugs: Diuretics

